Article
Patients with CDH23 mutations and the 1555A>G mitochondrial mutation are good candidates for electric acoustic stimulation (EAS).
Acta oto-laryngologica - 1 Apr 2012
Usami Shin-ichi, Miyagawa Maiko, Nishio Shin-ya, Moteki Hideaki, Takumi Yutaka, Suzuki Mika, Kitano Yoko, Iwasaki Satoshi
Abstract excerpt
CONCLUSIONS: CDH23 mutations and the 1555A>G mitochondrial mutation were identified among our series of electric acoustic stimulation (EAS) patients, confirming that these genes were important in hearing loss with involvement of high frequency. Successful hearing preservation as well as good outcomes from EAS indicated that patients with this combination of mutations are good candidates for EAS. OBJECTIVES:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
